Works by Azuma, Koichi


Results: 122
    1
    2

    Alternating Therapy With Osimertinib and Afatinib Blockades EGFR Secondary Mutation in EGFR-Mutant Lung Cancer: A Single-Arm Phase II Trial.

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 6, p. 519, doi. 10.1016/j.cllc.2023.05.008
    By:
    • Kimio Yonesaka;
    • Hidetoshi Hayashi;
    • Atsushi Nakamura;
    • Yuki Sato;
    • Koichi Azuma;
    • Shinya Sakata;
    • Motoko Tachihara;
    • Satoshi Ikeda;
    • Toshihide Yokoyama;
    • Kentaro Ito;
    • Yukihiro Yano;
    • Hirotaka Matsumoto;
    • Haruko Daga;
    • Akito Hata;
    • Kazuko Sakai;
    • Yasutaka Chiba;
    • Kazuto Nishio;
    • Nobuyuki Yamamoto;
    • Kazuhiko Nakagawal
    Publication type:
    Article
    3
    4
    5

    Glecaprevir and pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real‐world cohort study.

    Published in:
    Hepatology Research, 2019, v. 49, n. 6, p. 617, doi. 10.1111/hepr.13328
    By:
    • Ogawa, Eiichi;
    • Furusyo, Norihiro;
    • Nakamuta, Makoto;
    • Nomura, Hideyuki;
    • Satoh, Takeaki;
    • Takahashi, Kazuhiro;
    • Koyanagi, Toshimasa;
    • Kajiwara, Eiji;
    • Dohmen, Kazufumi;
    • Kawano, Akira;
    • Ooho, Aritsune;
    • Azuma, Koichi;
    • Kato, Masaki;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    6
    7

    First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study.

    Published in:
    Japanese Journal of Clinical Oncology, 2024, v. 54, n. 4, p. 452, doi. 10.1093/jjco/hyad195
    By:
    • Imai, Hisao;
    • Kijima, Takashi;
    • Azuma, Koichi;
    • Kishi, Kazuma;
    • Saito, Haruhiro;
    • Yamaguchi, Teppei;
    • Tanizaki, Junko;
    • Yoneshima, Yasuto;
    • Fujita, Kohei;
    • Watanabe, Satoshi;
    • Kitazono, Satoru;
    • Fukuhara, Tatsuro;
    • Hataji, Osamu;
    • Toi, Yukihiro;
    • Mizutani, Hideaki;
    • Hamakawa, Yusuke;
    • Maemondo, Makoto;
    • Ohsugi, Tomoyuki;
    • Suzuki, Keisuke;
    • Horinouchi, Hidehito
    Publication type:
    Article
    8
    9
    10
    11

    Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.

    Published in:
    Cancers, 2020, v. 12, n. 9, p. 2602, doi. 10.3390/cancers12092602
    By:
    • Ogawa, Eiichi;
    • Nomura, Hideyuki;
    • Nakamuta, Makoto;
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Dohmen, Kazufumi;
    • Kawano, Akira;
    • Ooho, Aritsune;
    • Azuma, Koichi;
    • Takahashi, Kazuhiro;
    • Satoh, Takeaki;
    • Koyanagi, Toshimasa;
    • Ichiki, Yasunori;
    • Kuniyoshi, Masami;
    • Yanagita, Kimihiko;
    • Amagase, Hiromasa;
    • Morita, Chie;
    • Sugimoto, Rie;
    • Kato, Masaki;
    • Shimoda, Shinji
    Publication type:
    Article
    12
    13
    14

    Predicting osimertinib‐treatment outcomes through EGFR mutant‐fraction monitoring in the circulating tumor DNA of EGFR T790M‐positive patients with non‐small cell lung cancer (WJOG8815L).

    Published in:
    Molecular Oncology, 2021, v. 15, n. 1, p. 126, doi. 10.1002/1878-0261.12841
    By:
    • Sakai, Kazuko;
    • Takahama, Takayuki;
    • Shimokawa, Mototsugu;
    • Azuma, Koichi;
    • Takeda, Masayuki;
    • Kato, Terufumi;
    • Daga, Haruko;
    • Okamoto, Isamu;
    • Akamatsu, Hiroaki;
    • Teraoka, Shunsuke;
    • Ono, Akira;
    • Ohira, Tatsuo;
    • Yokoyama, Toshihide;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko;
    • Nishio, Kazuto
    Publication type:
    Article
    15
    16

    A phase I study of S-1 with concurrent radiotherapy in elderly patients with locally advanced non-small cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 3, p. 599, doi. 10.1007/s10637-012-9833-7
    By:
    • Hasegawa, Yoshikazu;
    • Okamoto, Isamu;
    • Takezawa, Ken;
    • Miyazaki, Masaaki;
    • Tsurutani, Junji;
    • Yonesaka, Kimio;
    • Morinaga, Ryotaroh;
    • Tsuya, Asuka;
    • Terashima, Masaaki;
    • Kudoh, Toshihiro;
    • Azuma, Koichi;
    • Kurata, Takayasu;
    • Nishikawa, Tatsuyuki;
    • Fukuoka, Masahiro;
    • Nishimura, Yasumasa;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    17

    An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin.

    Published in:
    Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 5, p. 689, doi. 10.1007/s10156-012-0396-5
    By:
    • Ogawa, Eiichi;
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Takahashi, Kazuhiro;
    • Nomura, Hideyuki;
    • Tanabe, Yuichi;
    • Satoh, Takeaki;
    • Maruyama, Toshihiro;
    • Nakamuta, Makoto;
    • Kotoh, Kazuhiro;
    • Azuma, Koichi;
    • Dohmen, Kazufumi;
    • Shimoda, Shinji;
    • Hayashi, Jun
    Publication type:
    Article
    18
    19

    Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

    Published in:
    Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898
    By:
    • Yoshiro Nakahara;
    • Taku Kouro;
    • Satoru Motoyama;
    • Masatomo Miura;
    • Kazuma Fujita;
    • Yuka Igarashi;
    • Naoko Higashijima;
    • Norikazu Matsuo;
    • Hidetomo Himuro;
    • Feifei Wei;
    • Shun Horaguchi;
    • Kayoko Tsuji;
    • Yasunobu Mano;
    • Mitsuru Komahashi;
    • Haruhiro Saito;
    • Koichi Azuma;
    • Tetsuro Sasada
    Publication type:
    Article
    20

    Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

    Published in:
    Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898
    By:
    • Yoshiro Nakahara;
    • Taku Kouro;
    • Satoru Motoyama;
    • Masatomo Miura;
    • Kazuma Fujita;
    • Yuka Igarashi;
    • Naoko Higashijima;
    • Norikazu Matsuo;
    • Hidetomo Himuro;
    • Feifei Wei;
    • Shun Horaguchi;
    • Kayoko Tsuji;
    • Yasunobu Mano;
    • Mitsuru Komahashi;
    • Haruhiro Saito;
    • Koichi Azuma;
    • Tetsuro Sasada
    Publication type:
    Article
    21

    Circulating IL-6 and not its circulating signaling components sIL-6R and sgp130 demonstrate clinical significance in NSCLC patients treated with immune checkpoint inhibitors.

    Published in:
    Frontiers in Cell & Developmental Biology, 2024, p. 1, doi. 10.3389/fcell.2023.1324898
    By:
    • Yoshiro Nakahara;
    • Taku Kouro;
    • Satoru Motoyama;
    • Masatomo Miura;
    • Kazuma Fujita;
    • Yuka Igarashi;
    • Naoko Higashijima;
    • Norikazu Matsuo;
    • Hidetomo Himuro;
    • Feifei Wei;
    • Shun Horaguchi;
    • Kayoko Tsuji;
    • Yasunobu Mano;
    • Mitsuru Komahashi;
    • Haruhiro Saito;
    • Koichi Azuma;
    • Tetsuro Sasada
    Publication type:
    Article
    22
    23

    Blood Pressure Variability As Well As Blood Pressure Level is Important for Left Ventricular Hypertrophy and Brachial-Ankle Pulse Wave Velocity in Hypertensives.

    Published in:
    Clinical & Experimental Hypertension, 2009, v. 31, n. 8, p. 669, doi. 10.3109/10641960903407033
    By:
    • Ozawa, Motoko;
    • Tamura, Kouichi;
    • Okano, Yasuko;
    • Matsushita, Kouhei;
    • Ikeya, Yuko;
    • Masuda, Shinichiro;
    • Wakui, Hiromichi;
    • Dejima, Toru;
    • Shigenaga, Atsu-Ichiro;
    • Azuma, Koichi;
    • Ishigami, Tomoaki;
    • Toya, Yoshiyuki;
    • Ishikawa, Toshiyuki;
    • Umemura, Satoshi
    Publication type:
    Article
    24

    Ambulatory Blood Pressure Variability Is Increased in Diabetic Hypertensives.

    Published in:
    Clinical & Experimental Hypertension, 2008, v. 30, n. 3/4, p. 213, doi. 10.1080/10641960802068477
    By:
    • Ozawa, Motoko;
    • Tamura, Kouichi;
    • Iwatsubo, Kousaku;
    • Matsushita, Kouhei;
    • Sakai, Masashi;
    • Tsurumi-Ikeya, Yuko;
    • Azuma, Koichi;
    • Shigenaga, Atsuichiro;
    • Okano, Yasuko;
    • Masuda, Shinichiro;
    • Wakui, Hiromichi;
    • Ishigami, Tomoaki;
    • Umemura, Satoshi
    Publication type:
    Article
    25

    Ambulatory Blood Pressure and Heart Rate in Hypertensives with Renal Failure: Comparison between Diabetic Nephropathy and Non-Diabetic Glomerulopathy.

    Published in:
    Clinical & Experimental Hypertension, 2008, v. 30, n. 1, p. 33, doi. 10.1080/10641960701813890
    By:
    • Tamura, Kouichi;
    • Yamauchi, Junji;
    • Tsurumi-Ikeya, Yuko;
    • Sakai, Masashi;
    • Ozawa, Motoko;
    • Shigenaga, Atsuichiro;
    • Azuma, Koichi;
    • Okano, Yasuko;
    • Ishigami, Tomoaki;
    • Toya, Yoshiyuki;
    • Yabana, Machiko;
    • Tokita, Yasuo;
    • Ohnishi, Toshimasa;
    • Umemura, Satoshi
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L).

    Published in:
    Cancer Management & Research, 2021, v. 13, p. 9167, doi. 10.2147/CMAR.S336262
    By:
    • Tachihara, Motoko;
    • Tsujino, Kayoko;
    • Ishihara, Takeaki;
    • Hayashi, Hidetoshi;
    • Sato, Yuki;
    • Kurata, Takayasu;
    • Sugawara, Shunichi;
    • Okamoto, Isamu;
    • Teraoka, Shunsuke;
    • Azuma, Koichi;
    • Daga, Haruko;
    • Yamaguchi, Masafumi;
    • Kodaira, Takeshi;
    • Satouchi, Miyako;
    • Shimokawa, Mototsugu;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    38
    39
    40
    41
    42

    Development of Hepatocellular Carcinoma in Patients Aged 75-84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals.

    Published in:
    2022
    By:
    • Ogawa, Eiichi;
    • Nomura, Hideyuki;
    • Nakamuta, Makoto;
    • Furusyo, Norihiro;
    • Kajiwara, Eiji;
    • Dohmen, Kazufumi;
    • Kawano, Akira;
    • Ooho, Aritsune;
    • Azuma, Koichi;
    • Takahashi, Kazuhiro;
    • Satoh, Takeaki;
    • Koyanagi, Toshimasa;
    • Ichiki, Yasunori;
    • Kuniyoshi, Masami;
    • Yanagita, Kimihiko;
    • Amagase, Hiromasa;
    • Morita, Chie;
    • Sugimoto, Rie;
    • Kato, Masaki;
    • Shimoda, Shinji
    Publication type:
    journal article
    43
    44

    Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 8, p. 661, doi. 10.1016/j.cllc.2024.07.001
    By:
    • Yosuke Kakiuchi;
    • Koichi Saruwatari;
    • Kenta Murotani;
    • Takaaki Tokito;
    • Toyohisa Iriki;
    • Jun Iwakawa;
    • Yoshihiko Sakata;
    • Naoki Shingu;
    • Sho Saeki;
    • Megumi Inaba;
    • Akira Takaki;
    • Shunsuke Misono;
    • Takayuki Suetsugu;
    • Koichi Azuma;
    • Keiko Mizuno;
    • Takuro Sakagami
    Publication type:
    Article
    45

    A Phase II Study to Assess the Efficacy of Osimertinib in Patients With EGFR Mutation-positive NSCLC Who Developed Isolated CNS Progression (T790M-negative or Unknown) During First- or Second-generation EGFR-TKI or Systemic Disease Progression (T790M-negative) After Treatment With First- or Second-generation EGFR-TKI and Platinum-based Chemotherapy (WJOG12819L)

    Published in:
    Clinical Lung Cancer, 2021, v. 22, n. 4, p. 376, doi. 10.1016/j.cllc.2020.12.009
    By:
    • Takeda, Masayuki;
    • Shimokawa, Mototsugu;
    • Nakamura, Atsushi;
    • Nosaki, Kaname;
    • Watanabe, Yasutaka;
    • Kato, Terufumi;
    • Hayakawa, Daisuke;
    • Tanaka, Hiroshi;
    • Takahashi, Toshiaki;
    • Kogure, Yoshihito;
    • Tachihara, Motoko;
    • Fujimoto, Daichi;
    • Yamaguchi, Kakuhiro;
    • Hamaguchi, Naohiko;
    • Okamoto, Isamu;
    • Azuma, Koichi;
    • Hasegawa, Kazuo;
    • Yamamoto, Nobuyuki;
    • Nakagawa, Kazuhiko
    Publication type:
    Article
    46

    Treatment Rationale and Design for APPLE (WJOG11218L): A Multicenter, Open-Label, Randomized Phase 3 Study of Atezolizumab and Platinum/Pemetrexed With or Without Bevacizumab for Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer.

    Published in:
    2020
    By:
    • Shiraishi, Yoshimasa;
    • Kishimoto, Junji;
    • Tanaka, Kentaro;
    • Sugawara, Shunichi;
    • Daga, Haruko;
    • Hirano, Katsuya;
    • Azuma, Koichi;
    • Hataji, Osamu;
    • Hayashi, Hidetoshi;
    • Tachihara, Motoko;
    • Mitsudomi, Tetsuya;
    • Seto, Takashi;
    • Nakagawa, Kazuhiko;
    • Yamamoto, Nobuyuki;
    • Okamoto, Isamu
    Publication type:
    journal article
    47
    48
    49
    50